AASLD/EASL HCV Special Conference: Therapy of Hepatitis C

To evaluate the impact of new strategies for screening of hepatitis C in the United States and abroad
To understand the changing global epidemiology of HCV infection
To recognize the role and limitations of non-invasive tests for staging hepatic fibrosis
To understand the strengths and limitations of recently approved therapeutic regimens compared to first generation triple therapy regimens
To understand barriers to care and identify potential solutions to improve global access to new HCV therapies